Literature DB >> 9606710

A novel and efficient method for the stable expression of heteromeric ion channels in mammalian cells.

E Kawashima1, D Estoppey, C Virginio, D Fahmi, S Rees, A Surprenant, R A North.   

Abstract

The 5' untranslated leader sequence from the encephalomyocarditis virus was used to engineer bicistronic or tricistronic expression vectors encoding two subunits (P2X2 and P2X3) of an ATP-gated cation channel. Human embryonic kidney (293) and chinese hamster ovary (CHO-K1) cells were transfected with the vector, and stable cell lines were generated by single cell subcloning. Selection was made in a 96-well format on the basis of a sustained increase in intracellular calcium (fluorescence of Fluo3-loaded cells) evoked by the ATP analog alpha beta methylene ATP. A high proportion of transformants expressed heteromeric receptors containing both P2X2 and P2X3 subunits, as evidenced by a nondesensitizing current in response to alpha beta methylene ATP. The method is fast and simple and could be generally useful for the stable expression of heteromultimeric channel proteins.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9606710

Source DB:  PubMed          Journal:  Receptors Channels        ISSN: 1060-6823


  11 in total

1.  Kinetics of antagonist actions at rat P2X2/3 heteromeric receptors.

Authors:  Valeria Spelta; Lin-Hua Jiang; Annmarie Surprenant; R Alan North
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

2.  The role of pannexin 1 hemichannels in ATP release and cell-cell communication in mouse taste buds.

Authors:  Yi-Jen Huang; Yutaka Maruyama; Gennady Dvoryanchikov; Elizabeth Pereira; Nirupa Chaudhari; Stephen D Roper
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-26       Impact factor: 11.205

3.  The antagonist trinitrophenyl-ATP reveals co-existence of distinct P2X receptor channels in rat nodose neurones.

Authors:  S Thomas; C Virginio; R A North; A Surprenant
Journal:  J Physiol       Date:  1998-06-01       Impact factor: 5.182

4.  Characterization of three diaminopyrimidines as potent and selective antagonists of P2X3 and P2X2/3 receptors with in vivo efficacy in a pain model.

Authors:  E Ballini; C Virginio; S J Medhurst; S G Summerfield; L Aldegheri; A Buson; C Carignani; Y H Chen; A Giacometti; I Lago; A J Powell; W Jarolimek
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

5.  Calcium permeability and block at homomeric and heteromeric P2X2 and P2X3 receptors, and P2X receptors in rat nodose neurones.

Authors:  C Virginio; R A North; A Surprenant
Journal:  J Physiol       Date:  1998-07-01       Impact factor: 5.182

6.  Methyllycaconitine, alpha-bungarotoxin and (+)-tubocurarine block fast ATP-gated currents in rat dorsal root ganglion cells.

Authors:  Ulyana Lalo; Yuri Pankratov; Oleg Krishtal; R Alan North
Journal:  Br J Pharmacol       Date:  2004-07-26       Impact factor: 8.739

7.  Carbon monoxide is a rapid modulator of recombinant and native P2X(2) ligand-gated ion channels.

Authors:  W J Wilkinson; H C Gadeberg; A W J Harrison; N D Allen; D Riccardi; P J Kemp
Journal:  Br J Pharmacol       Date:  2009-08-19       Impact factor: 8.739

8.  ATP analogues with modified phosphate chains and their selectivity for rat P2X2 and P2X2/3 receptors.

Authors:  Valeria Spelta; Abdelaziz Mekhalfia; Dominik Rejman; Mark Thompson; G Michael Blackburn; R Alan North
Journal:  Br J Pharmacol       Date:  2003-10-27       Impact factor: 8.739

9.  Inefficient constitutive inhibition of P2X3 receptors by brain natriuretic peptide system contributes to sensitization of trigeminal sensory neurons in a genetic mouse model of familial hemiplegic migraine.

Authors:  Anna Marchenkova; Sandra Vilotti; Niels Ntamati; Arn Mjm van den Maagdenberg; Andrea Nistri
Journal:  Mol Pain       Date:  2016-05-12       Impact factor: 3.395

10.  Brain natriuretic peptide constitutively downregulates P2X3 receptors by controlling their phosphorylation state and membrane localization.

Authors:  Anna Marchenkova; Sandra Vilotti; Elsa Fabbretti; Andrea Nistri
Journal:  Mol Pain       Date:  2015-11-14       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.